胰腺癌化学药物治疗现状及其发展方向

被引:8
作者
廖泉
赵玉沛
机构
[1] 中国医学科学院中国协和医科大学北京协和医院外科
关键词
胰腺癌; 平均; 干扰素; 生存时间; 手术切除; 反应率; 胰腺肿瘤; 抗病毒药; 化学药物; 化疗药物;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
摘要
引用
收藏
页码:45 / 47
页数:3
相关论文
共 6 条
[1]  
Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: A Mid-Atlantic Oncology Program study[J] . M. Auerbach,G. L. Wampler,J. J. Lokich,D. Fryer,J. G. Fryer,J. D. Ahlgren.Annals of Oncology . 1997 (5)
[2]  
Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers[J] . Helmut Friess,Michael Gassmann,Markus W. Büchler.International Journal of Pancreatology . 1997 (1)
[3]  
Multimodal therapies in ductal pancreatic cancer[J] . Karl-Heinrich Link,Frank Gansauge,Jürgen Pillasch,Hans-Günther Beger.International Journal of Pancreatology . 1997 (1)
[4]  
Results of adjuvant therapy in resected pancreatic cancer[J] . International Journal of Pancreatology . 1997 (1)
[5]  
Adjuvant chemotherapy in pancreatic cancer[J] . Simon R. Bramhall,John P. Neoptolemos.International Journal of Pancreatology . 1997 (1)
[6]  
Celiac artery adjuvant chemotherapy[J] . Karl-Heinrich Link,Frank Gansauge,Norbert Rilinger,Hans-Günther Beger.International Journal of Pancreatology . 1997 (1)